Skip to main content

Advertisement

Log in

Design and Evaluation of a Novel Matrix Type Multiple Units as Biphasic Gastroretentive Drug Delivery Systems

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

A biphasic gastroretentive floating drug delivery system with multiple-unit mini-tablets based on gas formation technique was developed to maintain constant plasma level of a drug concentration within the therapeutic window. The system consists of loading dose as uncoated core units, and prolonged-release core units are prepared by direct compression process; the latter were coated with three successive layers, one of which is seal coat, an effervescent (sodium bicarbonate) layer, and an outer polymeric layer of polymethacrylates. The formulations were evaluated for quality control tests, and all the parameters evaluated were within the acceptable limits. The system using Eudragit RL30D and combination of them as polymeric layer could float within acceptable time. The drug release was linear with the square root of time. The rapid floating and the controlled release properties were achieved in this present study. When compared with the theoretical release profile, the similarity factor of formulation with coating of RS:RL (1:3)–7.5%, was observed to be 74, which is well fitted into zero-order kinetics confirming that the release from formulation is close to desired release profile. The stability samples showed no significant change in dissolution profiles (p > 0.05). In vivo gastric residence time was examined by radiograms, and it was observed that the units remained in the stomach for about 5 h.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. A. C. Shah. Design of oral sustained release drug delivery systems: in vitro/in vivo Considerations. In A. Yacobi, and E. Halperin-Walega (eds.), Oral Sustained Release Formulation Design and Evaluation, Pergamon, New York, 1988, pp. 35–56.

    Google Scholar 

  2. A. Rubinstein, V. H. K. Li, P. Gruber, and J. R. Robinson. Gastrointestinal-physiological variables affecting the performance of oral sustained release dosage forms. In A. Yacobi, and E. Halperin-Walega (eds.), Oral Sustained Release Formulation Design and Evaluation, Pergamon, New York, 1988, pp. 125–156.

    Google Scholar 

  3. M. Mayersohn. Principles of drug absorption. In G. C. Banker, and C. T. Rhodes (eds.), Modern Pharmaceutics, Marcel Dekker, New York, 1979, pp. 23–89.

    Google Scholar 

  4. P. K. Gupta, and J. R. Robinson. Oral controlled-release delivery. In A. Kydonieus (ed.), Treatise on Controlled Drug Delivery, Marcel Dekker, New York, 1992, pp. 255–313.

    Google Scholar 

  5. N. Rouge, E. T. Cole, E. Doelker, and P. Buri. Screening of potentially floating excipients for Minitablets. S.T.P. Pharm. Sci. 7:386–392 (1997).

    CAS  Google Scholar 

  6. L. Maggi, E. O. Machiste, M. L. Torre, and U. Conte. Formulation of biphasic release tablets containing slightly soluble drugs. Eur. J. Pharm. Biopharm. 48:37–42 (1999).

    Article  PubMed  CAS  Google Scholar 

  7. S. Somade, and K. Singh. Comparative evaluation of wet granulation and direct compression methods for preparation of controlled release ranitidine HCL tablets. Indian J. Pharm. Sci. 64:285 (2002).

    Google Scholar 

  8. K. Lauritsen. Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases. Clin. Pharmacokinet. 1911–31:94–125 (1990).

    Article  PubMed  CAS  Google Scholar 

  9. S. Grant. Ranitidine: an updated review of its pharmacodynamics and pharmacokinetic properties and therapeutic use in peptic ulcer and other allied diseases. Drugs. 37:801–870 (1989).

    Article  PubMed  CAS  Google Scholar 

  10. A. Basit, and L. Lacey. Colonic metabolism of ranitidine: implications for its delivery and absorption. Int. J. Pharm. 227:157–165 (2001).

    Article  PubMed  CAS  Google Scholar 

  11. M. Coffin, and A. Parr, inventors. Glaxo Inc. Ranitidine solid dosage form. US patent 5 407 687. April 18, 1995.

  12. J. G. Wagner. Biopharmaceutics and pharmacokinetics. 1st ed. Org. Intelligence publications, 22, 1971, pp. 148–157.

  13. A. M. Hamid, M. S. Harris, T. Jaweria, and I. Y. Rabia. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech. 7:(3) Article 78 (2006).

    Google Scholar 

  14. P. Costa, and J. M. S. Lobo. Modeling and comparison dissolution profiles. Int. J. Pharm. 13:123–133 (2001).

    CAS  Google Scholar 

  15. J. W. Moore, and H. H. Flanner. Mathematical comparison of curves with an emphasis on in- vitro dissolution profiles. Pharm. Tech. 20:64–74 (1996).

    Google Scholar 

  16. P. Colombo, R. Bettini, P. Santi, and N. A. Peppas. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. PSTT. 3:198–204 (2000).

    CAS  Google Scholar 

  17. S. Kiil, and K. Dam-Johansen. Controlled drug delivery from swellable Hydroxyl propyl methylcellulose matrices: model-based analysis of observed radial front movements. J. Contr. Release. 90:1–21 (2003).

    Article  CAS  Google Scholar 

  18. I. Krögel, and R. Bodmeier. Floating or pulsatile drug delivery systems based on coated effervescent cores. Int. J. Pharm. 187:175–184 (1999).

    Article  PubMed  Google Scholar 

  19. V. Iannuccelli, G. Coppi, M. T. Bernabei, and R. Cameroni. Air compartment multipleunit system for prolonged gastric residence. Part I. Formulation study. Int. J. Pharm. 174:47–54 (1998).

    Article  CAS  Google Scholar 

  20. I. Ghebre-Sellassie, R. U. Nesbitt, and J. Wang. Eudragit aqueous dispersions as pharmaceutical controlled release coatings. In J. W. McGinity (ed.), Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, 2nd ed., Marcel Dekker, New York, pp. 267–286.

  21. K. H. Bauer, K. Lehmann, H. P. Osterwald, and G. Rothgang. Coated Pharmaceutical Dosage Forms, Medpharm Scientific, Stuttgart, 1998, pp. 63–119.

    Google Scholar 

  22. M. Ichigawa, S. Watanabe, and Y. Miyake. A new multiple-unit oral floating dosage system. I. Preparation and in vitro evaluation of floating and sustained release characteristics. J. Pharm. Sci. 80:1062–1066 (1991).

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr Reddy’s Laboratories (Hyderabad, India) for providing the gift sample of ranitidine hydrochloride, and one of the authors (Meka Lingam) is thankful to the UGC India for providing Junior Research Fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yamsani Madhusudan Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lingam, M., Ashok, T., Venkateswarlu, V. et al. Design and Evaluation of a Novel Matrix Type Multiple Units as Biphasic Gastroretentive Drug Delivery Systems. AAPS PharmSciTech 9, 1253–1261 (2008). https://doi.org/10.1208/s12249-008-9173-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9173-2

Key words

Navigation